Ethylene

Ethylene

SCHEMBL6994468

C=C.CCOC(C)OCC.O=C1CN(CCCN2CCN(c3ccc(F)cc3)CC2)S(=O)(=O)c2cc(Cl)ccc21

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 14/20 0.41
HTR1A P08908 11/20 0.41
HTR2A P28223 11/20 0.41
DRD3 P35462 10/20 0.41
HRH1 P35367 5/20 0.41
HTR2C P28335 5/20 0.41
DRD4 P21917 4/20 0.41
TMEM97 Q5BJF2 5/20 0.41
SIGMAR1 Q99720 5/20 0.41
DRD1 P21728 5/20 0.41
DRD5 P21918 4/20 0.41
HTR6 P50406 4/20 0.41
SLC6A4 P31645 3/20 0.41
SLC6A3 Q01959 3/20 0.41
CHRM1 P11229 1/20 0.41
HTR2B P41595 1/20 0.41
SLC6A2 P23975 2/20 0.40
CACNA1G O43497 1/20 0.40
HTR7 P34969 4/20 0.39
MAPT P10636 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL6996875 0.94 CACNA1G (0.41) DRD2HTR1AHTR2ADRD3HRH1
Ethylene SCHEMBL6996024 0.90 ALOX15 (0.42) DRD2HTR1AHTR2AHTR2CDRD4
Ethylene SCHEMBL6995999 0.89 DRD2 (0.45) DRD2HTR1AHTR2ADRD3HRH1
Ethylene SCHEMBL6998179 0.87 DRD2 (0.47) DRD2HTR1AHTR2ADRD3HRH1
Ethylene SCHEMBL6994585 0.87 DRD2 (0.54) DRD2HTR1AHTR2ADRD3DRD4
Ethylene SCHEMBL6990074 0.86 DRD2 (0.41) DRD2HTR2AHTR2CHTR6HTR7
Ethylene SCHEMBL6996869 0.85 HTR1A (0.44) DRD2HTR1AHTR2AHTR2CDRD4
Ethylene SCHEMBL6996554 0.84 DRD2 (0.43) DRD2HTR1AHTR2ADRD3HRH1
Ethylene SCHEMBL6991302 0.83 TDP1 (0.42) DRD2HTR1AHTR2ADRD3HRH1
Ethylene SCHEMBL6999382 0.82 TDP1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6664251-B2 Serotonin receptor antagonist; treating cardiovascular disorder DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2003-12-16 US disclosed
US-20030078256-A1 Benzothiazine derivative SUNTORY LIMITED (JP) 2003-04-24 US disclosed
EP-0749967-B1 Substituted benzothiazine derivative SUNTORY LTD (JP) 2003-01-22 EP disclosed
US-6316442-B1 TREATMENT OF HEART DISEASE AND CEREBROVASCULAR DISTURBANCES SUNTORY LIMITED (JP) 2001-11-13 US disclosed
US-6001827-A Benzothiazine derivative SUNTORY LIMITED (JP) 1999-12-14 US disclosed
EP-0749967-A1 Substituted benzothiazine derivative SUNTORY LIMITED (JP) 1996-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078256-A1 Benzothiazine derivative TPH2, ADRB2, TPH1 DRD2 402/4885HTR1A 7/4885HTR2A 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.